Healthequity Inc
SWB:2HE

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
SWB:2HE
Watchlist
Price: 77.5 EUR 4.73% Market Closed
Market Cap: €3.6B

Wall St Price Targets

2HE Price Targets Summary
Healthequity Inc

Wall Street analysts forecast 2HE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2HE is 87.39 EUR with a low forecast of 66.18 EUR and a high forecast of 105.55 EUR.

Lowest Forecast
Price Target
66.18 EUR
15% Downside
Average Forecast
Price Target
87.39 EUR
13% Upside
Highest Forecast
Price Target
105.55 EUR
36% Upside
Healthequity Inc Competitors:
Price Targets

Revenue
Forecast

29% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
29% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 3 years is 8%.

Gross Profit
Forecast

32% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
32% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 12 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 3 years is 10%.

Operating Income
Forecast

32% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
32% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 12 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 3 years is 23%.

Pre-Tax Income
Forecast

39% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
39% / Year
Past Growth
34% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 34%.

Net Income
Forecast

N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss
N/A
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-26%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 31%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2HE's stock price target?
Price Target
87.39 EUR

According to Wall Street analysts, the average 1-year price target for 2HE is 87.39 EUR with a low forecast of 66.18 EUR and a high forecast of 105.55 EUR.

What is the Revenue forecast for Healthequity Inc?
Projected CAGR
8%

Over the last 12 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for Healthequity Inc?
Projected CAGR
10%

Over the last 12 years, the compound annual growth rate for Gross Profit has been 32%. The projected CAGR for the next 3 years is 10%.

What is the Operating Income forecast for Healthequity Inc?
Projected CAGR
23%

Over the last 12 years, the compound annual growth rate for Operating Income has been 32%. The projected CAGR for the next 3 years is 23%.

What is the Pre-Tax Income forecast for Healthequity Inc?
Projected CAGR
34%

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 34%.

What is the Net Income forecast for Healthequity Inc?
Projected CAGR
31%

The compound annual growth rate for Net Income over the next 3 years is 31%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett